AIM rules

Description of the business

To see the Company’s description of the business, please click here

Board of Directors and biographical details

To see the names of the Company’s Directors, their biographical details and their responsibilities, please click here

Corporate Governance

To see information on the Company’s Corporate Governance, please click here

Board committees

To see the Company’s Board Committees and the list of members in these committees, please click here for the Remuneration committee click here for the Audit committee

Country of incorporation and main country of operation

The Company was incorporated in the United Kingdom in 2006, and is based in Leeds. Tissue Regenix’s main country of operation is the United Kingdom, but it also has an operation in Texas, United States of America.

The Company is subject to the United Kingdom’s City Code on Takeovers and Mergers.

Current constitutional documents

To see the Company’s reports & documents, please click here

Number of securities in issue

Shares not in public hands as at 29 November 2024 - 40,732,660 - 57.05%

Shares in issue as at 29 November 2024 - 71,395,635 ordinary shares of 0.1p each

Identity and percentage holdings of significant shareholders

To see the Company’s significant shareholders list, please click here

Company announcements and notifications

To see all notifications made by the Company in the past 12 months, please click here

Admission Document and circulars

To see the Company’s reports & documents, please click here

Advisors

To see the Company’s advisors, please click here

Company Contact Details

To see the Company’s contact details, please click here

Exchange/Trading Platform

The securities of Tissue Regenix Group plc are traded on the AIM market operated by the London Stock Exchange plc. Its shares have not been admitted, nor have any applications been made, for any of its shares to be admitted or traded on any other exchanges or trading platform.

Share Restrictions

There are no restrictions on the transfer of shares.

AGM Votes

To view the voting record for the June 2020 Annual General Meeting, click here